Navigation Links
70-year-old, Three Sons Seek Mercy Death

An impoverished 70-year-old man and his three physically challenged sons have sought permission from India's president to end their lives , saying there seemed to be little hope for the family.

"With nobody to extend a helping hand, death is probably a wise option," says 70-year-old Hakimuddin, a resident of Kamalpur village in Bhadrak district.

His three sons, Raffiuddin, 35, Mayiuddin, 33, and Mustaffa, 30, are stated to be suffering from a rare genetic disease - that weakens the limbs - since they were 15 years old. They have no money to seek treatment.

"Doctors at the district headquarters hospital couldn't cure the disease. I have already spent all my money for their treatment. I don't have the means to consult renowned physicians outside the state and even in the SCB Medical College at Cuttack. Nobody is coming forward to help me," Hakimuddin told IANS.

He and his wife have worked as daily wage labourers and managed to make ends meet for their seven-member family. Hakimuddin has so far dutifully looked after his three disabled sons.

"I do all their day to day work. But with my husband turning 70, it is very difficult for us to bear the responsibilities. He is now unable to work and many times we have to go without food at night," said 58-year-old Kalsum Bibi, wife of Hakimuddin.

To add to their woes, their thatched house, which was partially damaged in the 1999 super-cyclone, is yet to be repaired.

"Surprisingly, despite being poor, they have not been included in the below the poverty line list and have not been able to get a house under the Indira Awas Yojana," said Mayinuddin Khan, a neighbour.

Despite repeated requests, neither government officials nor local political leaders have done anything for Hakimuddin's family. Finally they have appealed for mercy death.

"In my letter to the President of India, prime minister and Orissa chie
'"/>




Page: 1 2

Related medicine news :

1. 70-year-old, Three Sons Seek Mercy Death
2. One in Three Heart Attack Patients Have No Chest Pains
3. Nobel Prize for Medicine shared by Three scientists
4. Three Tropical Parasites Genetic Code Unravelled
5. The Future Pattern Of Weight Gain Is Laid As Early As Three Years Of Age
6. Smoking Increases The Risk Of Heart Disease By Three Times
7. Three Sisters Have One Baby and Make History
8. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
9. Three More Bird Flu Cases Reported By China
10. Three meals daily Keeps Keralas elderly Healthy
11. Three dimensional structure of apolipoprotein revealed
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: year old Three Sons Seek Mercy Death

(Date:12/2/2008)...ed with radiation prior to surgery for advanced re...nce and better overall survival rates, according t...ed a treatment called neoadjuvant therapy, which c... of cancer, before surgery to remove the tumor. Ne...radiation. , Neoadjuvant therapy should not be ...
(Date:12/2/2008)...n the December 1, 2008, issue of Clinical Cancer ...or Cancer Research, show lapatinib benefits women ... HER2-negative breast cancer or those who express ...ion, a misclassification of metastatic breast canc... people from receiving optimal therapy. , Lapat...
(Date:12/2/2008)...FirstCall/ - NUCRYST Pharmaceuticals Corp., a deve...ght infection and inflammation, announced today th...jority shareholder, The Westaim Corporation ("West...shareholders to consider a return of capital of US...tes to a return of capital of approximately US$15 ...
(Date:12/2/2008)...Call/ -- Today Pascal Metrics Inc.,publicly annou...sk management,services for hospitals and healthca...etrics rapidly has become a worldwide leader for c...d other regulatory requirements, to reduce,costs,...e patients safer from,medical failure and errors....
Breaking Medicine News(10 mins):Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2
... heart becomes so enlarged that it is no longer ab...s 35 in every 100,000 people. Researchers in the U...ished in the journal Science that a defect in the ...ays a key role in regulating the flow of calcium t...
...f The Anatomical Record has put together a collect...ry repair in animals. Spinal cord injury affects m...th little hope of living a normal life. However, r...tem cells - primitive cells that can turn into spe...
...ases in our society with more than five million pe...one. According to a major study in the UK, in whic...st 900,000 asthma patients across the UK, asthma s...t being prescribed the most suitable inhalers. The...
...at can often be fatal. Methadone has been one of t... However, the major concern in treating heroin add...ddictive. This is one reason methadone therapy is ...tudy has now found that an alternative drug therap...
Other Medicine News:
(Date:11/26/2008)...e-USNewswire/ -- Children whose eyes are misaligne... risk of developing mental illness by early adulth... published this month in Pediatrics , the official... , The retrospective study examined the medi...igned eyes) and compared them with records of chil...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-FirstCa...) announced today that it has received full approv...) for its U.S. pivotal trial to study the effectiv...associated therapy in the prevention of Contrast-I...approved PLC,s request to expand their investigati...
(Date:11/25/2008)...-USNewswire/ -- Kleinert Kutz and University of L...hand transplant on Messina, New York resident, Jan...Hand Care Center on Monday, November 24. The inno...ed shortly after 9 p.m. in a record nine hours. ,...prnh/20081125/DC48555-a ) , (Photo: http://ww...
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 1Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 2Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 3Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 4Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 1Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 1WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 3
... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e Acuity LT Central Monitoring Station allows emer... Delivery Area when and where it's needed. Central...-site in response to emergency situations to incre...nvolved., ,Used in conjunction with Welch Allyn's...
...ble and easy-to-use 3800 and 3900/P pulse oximeter...gy, the proprietary clinical patient motion algori...proved performance:, ,The 3800 and 3900 pulse.../ mechanical stress testing such as rough handling...
... the power of clinical information. , ,S/5 Clinic...ical connectivity solutions that help you and your...ent care. You will have access to essential patien...re team and specialists, independent of time and l...
...monitoring for intermediate care., ,The S/5 FM is...da S/5 product line., ,The S/5 FM has a modular d...tient Side Module (PSM) includes a comprehensive p...ECG, NIBP, motion-tolerant SpO 2 , 2 temperatures ...
Medicine Products: